SIBN
HealthcareSI-BONE Inc
$12.99-0.56 (-4.13%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving SIBN Today?
No stock-specific AI insight has been generated for SIBN yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$575M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume913K
Avg Volume (10D)—
Shares Outstanding44.2M
SIBN News
20 articles- SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026Yahoo Finance·Apr 30, 2026
- SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026Yahoo Finance·Apr 20, 2026
- Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers”Yahoo Finance·Mar 13, 2026
- SI-BONE, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 24, 2026
- Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolioMedicaldevice-network·Feb 24, 2026
- SI-BONE Inc (SIBN) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ...Yahoo Finance·Feb 24, 2026
- Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Feb 24, 2026
- SiBone Q4 Earnings Call HighlightsMarketbeat·Feb 23, 2026
- Si-Bone: Q4 Earnings SnapshotYahoo Finance·Feb 23, 2026
- Smith+Nephew signs distribution agreement with SI-BONEYahoo Finance·Feb 23, 2026
- SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 GuidanceYahoo Finance·Feb 23, 2026
- SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026Yahoo Finance·Feb 17, 2026
- Earnings Preview: Si-Bone (SIBN) Q4 Earnings Expected to DeclineYahoo Finance·Feb 16, 2026
- SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026Yahoo Finance·Feb 2, 2026
- SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025Yahoo Finance·Jan 12, 2026
- Assessing SI-BONE (SIBN) Valuation After Jim Cramer Endorsements And New Analyst CoverageYahoo Finance·Jan 12, 2026
- Does Cramer’s ‘Great, Great Speculation’ Tag Alter SI-BONE’s Risk Narrative and Niche Thesis (SIBN)?Yahoo Finance·Jan 10, 2026
- Jim Cramer on SI-BONE: “This is a Great, Great Speculation”Yahoo Finance·Jan 9, 2026
- Investors in SI-BONE (NASDAQ:SIBN) have seen favorable returns of 40% over the past yearYahoo Finance·Jan 5, 2026
- SI-Bone added to ‘Conviction List’, named ‘2026 Top Pick’ at NeedhamYahoo Finance·Dec 17, 2025
All 20 articles loaded
Price Data
Open$12.47
Previous Close$13.55
Day High$13.31
Day Low$12.18
52 Week High—
52 Week Low—
Fundamentals
Market Cap$575M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume913K
Avg Volume (10D)—
Shares Outstanding44.2M
About SI-BONE Inc
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
HealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK—
Composite FIGI—
Share Class FIGI—